BR112013031813A2 - composição para aplicação tópica - Google Patents

composição para aplicação tópica

Info

Publication number
BR112013031813A2
BR112013031813A2 BR112013031813A BR112013031813A BR112013031813A2 BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2 BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2
Authority
BR
Brazil
Prior art keywords
composition
topical application
topical
application
Prior art date
Application number
BR112013031813A
Other languages
English (en)
Inventor
Haim Bar-Simantov
Ofer Toledano
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of BR112013031813A2 publication Critical patent/BR112013031813A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
BR112013031813A 2011-06-29 2012-06-28 composição para aplicação tópica BR112013031813A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502725P 2011-06-29 2011-06-29
PCT/IL2012/050223 WO2013001536A1 (en) 2011-06-29 2012-06-28 Stabilized topical formulations containing core-shell microcapsules

Publications (1)

Publication Number Publication Date
BR112013031813A2 true BR112013031813A2 (pt) 2016-12-13

Family

ID=47423504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031813A BR112013031813A2 (pt) 2011-06-29 2012-06-28 composição para aplicação tópica

Country Status (13)

Country Link
US (1) US12053546B2 (pt)
EP (2) EP2726067B1 (pt)
JP (1) JP6033859B2 (pt)
KR (1) KR20140043397A (pt)
CN (2) CN103732217A (pt)
AU (1) AU2012277322A1 (pt)
BR (1) BR112013031813A2 (pt)
CA (1) CA2834681C (pt)
EA (1) EA201490178A1 (pt)
ES (2) ES2902498T3 (pt)
IL (1) IL229083A0 (pt)
MX (1) MX363379B (pt)
WO (1) WO2013001536A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1919606A2 (en) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
CA2732368C (en) 2008-07-31 2017-11-14 Sol-Gel Technologies Ltd. Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
ES2902498T3 (es) 2011-06-29 2022-03-28 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta
US9687465B2 (en) * 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US10046291B2 (en) 2013-12-06 2018-08-14 Kao Corporation Method for manufacturing microcapsules
WO2015092602A1 (en) * 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Topical pharmaceutical composition of a retinoid
GB201411704D0 (en) * 2014-07-01 2014-08-13 Lucideon Ltd Coated particles
WO2017029665A1 (en) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
CA3016464A1 (en) 2016-03-08 2017-09-14 Soo-Young Kang Long lasting cosmetic compositions
CN107260586B (zh) * 2017-06-27 2020-08-04 国珍健康科技(北京)有限公司 一种卸妆乳凝胶及其制备方法
CN110891561A (zh) 2017-07-12 2020-03-17 索尔-格尔科技有限公司 治疗痤疮的方法和组合物
EP3651756A4 (en) * 2017-07-12 2021-03-17 Sol-Gel Technologies Ltd. COMPOSITIONS WITH ENCAPSULATED TRETINOIN
CA3074843A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Long lasting cosmetic compositions
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
WO2019099966A1 (en) 2017-11-20 2019-05-23 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
WO2019195802A1 (en) 2018-04-05 2019-10-10 Bausch Health Ireland Limited Polymeric emulsion delivery systems
CN112041365A (zh) 2018-04-27 2020-12-04 生活实验公司 持久性化妆品组合物
CA3130441A1 (en) * 2019-02-19 2020-08-27 Sol-Gel Technologies Ltd. Method for treatment of moderate to severe erythema symptoms in rosacea patients
KR20230027073A (ko) * 2020-05-22 2023-02-27 솔-겔 테크놀로지스 리미티드 안정화된 마이크로캡슐, 그의 제조 방법 및 그의 용도
KR102220752B1 (ko) * 2020-08-13 2021-03-02 한국콜마주식회사 캡슐을 함유하는 화장료 조성물
CN116919939A (zh) * 2022-04-02 2023-10-24 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
CA2156931C (en) * 1993-02-26 2001-12-11 Julius R. Zecchino Titanium dioxide dispersions, cosmetic compositions and methods for using the same
SK279919B6 (sk) 1993-07-01 1999-05-07 Yamanouchi Europe B.V. Farmaceutický a kozmetický prostriedok na miestne
US5401517A (en) * 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) * 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
EP0934773B1 (en) 1998-02-06 2004-02-04 Seiwa Kasei Co., Ltd. Microcapsule having a specific wall and method for producing the same
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
US6303149B1 (en) 1998-08-13 2001-10-16 Sol-Gel Technologies, Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
DE60033279T2 (de) 1999-05-25 2007-11-22 Sol-Gel Technologies Ltd. Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
DE10182378T1 (de) 2000-04-21 2012-02-02 Sol-Gel Technologies Ltd. Zusammensetzung mit erhöter Formulationsstabilität und Verabreichung von topischen Wirkstoffen
US6979440B2 (en) * 2001-01-29 2005-12-27 Salvona, Llc Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric
DE10117842A1 (de) * 2001-04-04 2002-10-17 Coty Bv Kosmetische Vitamin-A-haltige Zubereitung
GB0119831D0 (en) 2001-08-14 2001-10-10 Unilever Plc Dual compartment packaged cosmetic composition
US6913825B2 (en) 2001-09-20 2005-07-05 University Of Notre Dame Du Lac Process for making mesoporous silicate nanoparticle coatings and hollow mesoporous silica nano-shells
US20030082217A1 (en) * 2001-10-25 2003-05-01 Isabelle Afriat Use of heat-stabilizing microcapsules to improve the activity or penetration of cosmetic or pharmaceutical active principles
US7923030B2 (en) * 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
BRPI0413131A (pt) 2003-07-31 2007-04-10 Sol Gel Technologies Ltd micro-cápsulas carregadas com ingredientes ativos e um método para sua preparação
WO2005097056A1 (de) 2004-04-05 2005-10-20 Cognis Ip Management Gmbh Wachmischung auf basis von partialglyceriden und pentaerythritestern
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
US20060014834A1 (en) 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
EP1919606A2 (en) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
EP2007210A4 (en) 2006-02-10 2011-07-06 Dupont Tate & Lyle Bio Products Company Llc COMPOSITIONS WITH MONO AND DIESELS FROM 1,3-PROPANEL ON BIOLOGICAL BASIS
US8158109B2 (en) 2006-03-31 2012-04-17 Stiefel Research Australia Pty Ltd Foamable suspension gel
BRPI0720068A2 (pt) 2006-12-12 2013-12-24 Sol Gel Technologies Ltd Processo para preparar nanocápsulas, produto, nanocápsulas e composição
MX2009008250A (es) 2007-02-01 2009-08-27 Sol Gel Technologies Ltd Composiciones para aplicacion topica que comprenden un peroxido y retinoide.
EP2118208B1 (en) 2007-02-01 2019-10-09 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
US8357318B2 (en) 2007-05-08 2013-01-22 Givaudan S.A. Wax encapsulation
EP2214661A4 (en) 2007-10-18 2012-10-03 Medicis Pharmaceutical Corp AQUEOUS RETINOID AND BENZOYL PEROXIDE GEL
US20090130220A1 (en) * 2007-11-20 2009-05-21 Johnson Pamela A Cosmetic composition having pomace olive oil
EP2364692B1 (fr) * 2007-11-30 2017-10-25 Galderma Research & Development Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
US9870123B1 (en) 2008-04-18 2018-01-16 Universal Electronics Inc. Selecting a picture of a device to identify an associated codeset
US20100029765A1 (en) 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
CA2732368C (en) 2008-07-31 2017-11-14 Sol-Gel Technologies Ltd. Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
CN102596186B (zh) 2009-12-31 2017-08-11 索尔-格尔科技有限公司 芯稳定的微胶囊、它们的制备方法以及它们的用途
ES2902498T3 (es) 2011-06-29 2022-03-28 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta

Also Published As

Publication number Publication date
CN107625743B (zh) 2021-08-27
CA2834681A1 (en) 2013-01-03
CA2834681C (en) 2019-03-12
AU2012277322A1 (en) 2013-11-14
MX363379B (es) 2019-03-21
EP3698778A1 (en) 2020-08-26
ES2902498T3 (es) 2022-03-28
EA201490178A1 (ru) 2014-04-30
EP3698778B1 (en) 2021-10-13
KR20140043397A (ko) 2014-04-09
EP2726067A1 (en) 2014-05-07
EP2726067B1 (en) 2020-02-19
US12053546B2 (en) 2024-08-06
CN107625743A (zh) 2018-01-26
ES2786103T3 (es) 2020-10-08
EP2726067A4 (en) 2014-12-24
WO2013001536A1 (en) 2013-01-03
JP6033859B2 (ja) 2016-11-30
CN103732217A (zh) 2014-04-16
IL229083A0 (en) 2013-12-31
US20130095185A1 (en) 2013-04-18
MX2013013722A (es) 2014-02-27
JP2014518259A (ja) 2014-07-28

Similar Documents

Publication Publication Date Title
BR112013031813A2 (pt) composição para aplicação tópica
SMT201600308B (it) Composti di benzene arile-o eteroarile-sostituiti
CR20130677A (es) FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
CO6801648A2 (es) Formulación para anticuerpo anti-α4β7
BR112014004395A2 (pt) composição
DK2694038T3 (da) Farmaceutisk sammensætning
BRDI7106210S (pt) Configuração aplicada para lâmina para microscópio
BR302012002270S1 (pt) Configuracao aplicada em motoneta
DK2730310T3 (da) Applikator
ES2977682T3 (es) Composición para la estimulación ovárica controlada
BR112013033808A2 (pt) composição
BR112014013682A2 (pt) composição para cuidado pessoal
BR112014009963A2 (pt) composição dietética
PT2694021E (pt) Composição cicatrizante para aplicação tópica
BR112014007030A2 (pt) composição
BR112013031544A2 (pt) composição tópica.
BR112014011723A2 (pt) composição antiperspirante
BR112013031220A2 (pt) composição tópica
BR112014013684A2 (pt) composição para cuidado pessoal
BR112013022907A2 (pt) composição farmacêutica
SMT201600068B (it) Composizione dolcificante
DK2726579T3 (da) Sammensætning

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]